Shares of Arqit Quantum (ARQQ) tumbled 10.2% to $14.28 on Thursday, extending a slide that has erased roughly 35% of the stock's value since early October, when the quantum-encryption software maker disclosed that a key Middle East contract had gone dark. The sell-off compounds a broader rout in software stocks, with the sector ETF down 4.65% and the Nasdaq off 2.14% — but Arqit's pain is overwhelmingly company-specific.

• One Broken Contract Wiped Out the Second-Half Growth Story. Second-half revenue came in at roughly $355,000–$380,000, down from $463,000 a year earlier, after Arqit stopped recognizing revenue on a material Middle East deal because geopolitical events impaired the customer's ability to perform.

That a single regional contract could drag down an entire half-year underscores dangerous customer-concentration risk.

• Full-Year Growth Masks a Tiny Revenue Base. Fiscal 2026 revenue is guided at $975,000–$1 million, nearly doubling from $530,000 in fiscal 2025. Impressive in percentage terms — but trivial in absolute dollars. Operating costs averaged $2.6 million per month in the first half , meaning the company spends in two weeks what it earns in a full year. The price-to-sales ratio sits at a staggering 331× , reflecting a valuation built entirely on future promise rather than present commercial traction.

• A $51 Million Cash Cushion Buys Time, Not Certainty. Arqit ended September with roughly $51 million in cash.

But operating cash burn reached $25.7 million in just the first half of fiscal 2026 , implying roughly a year of runway at current spending rates. The company has already leaned on share sales — issuing 846,911 shares via an at-the-market program to raise ~$18 million — so further dilution looms unless revenue accelerates sharply.

• A NATO Deal Offers Credibility, Not Revenue — Yet. On October 6, Arqit joined a winning consortium to supply secure networking services to NATO under a one-year contract with two renewal options.

However, the filing discloses neither contract value nor deployment scale , making it a validation milestone rather than a financial one. Converting defense engagements into recurring revenue remains the existential test for a company whose entire annual top line wouldn't cover a single month's expenses.